Day One - December 10, 2024

8:00 am Check In & Registration

8:55 am Chair’s Opening Remarks

Improving Ergonomic Program Management Across R&D, Manufacturing & Beyond

9:00 am Ergonomics – Ergonomics From The Office to Manufacturing – Strategies and Technological Innovations in Biopharma

  • Ann Marie Madera Senior Manager, Environmental Health & Safety, Eikon Therapeutics

9:30 am Roundtable Discussion: Navigating how to Quantitatively Measure Success in Ergonomic Plans

  • Sara Hamel Senior Manager, Environmental, Health, Safety & Sustainability, Kite Pharma

10:00 am Roundtable Discussion: Exploring New Initiatives to Reduce Serious Ergonomic Rates, Incidents & Numbers in Biopharma Manufacturing Sites

11:00 am Morning Break & Speed Networking

11:30 am Laboratory Design Considerations for Safety & Optimal Efficiency

  • Tom Evans Director, Facilities and Environmental Health & Safety, Halozyme Therapeutics

12:00 pm Roundtable Discussion: Balancing Environmental Safety & Control with Flexibility in Dynamic R&D Facilities – How Do Site Heads Strike a Balance?

12:30 pm Lunch

Integrating Sustainability into Environmental Health and Safety: Strategies for a Greener Future

1:30 pm Case Studies Connecting Sustainability and EHS

  • David Shoaf Senior Director - Health, Safety, Environment, & Security, Bayer
  • Regina Donaldson Site Engineering & Sustainability VACC and Energy Manager, Bayer

2:00 pm Grassroots Engagement for Sustainability Onsite: Growing Green Cultures in Biopharma

  • Sara Hamel Senior Manager, Environmental, Health, Safety & Sustainability, Kite Pharma

2:30 pm Sustainability by Design: Implementing EH&S Into Laboratory Environments

3:00 pm ISO 14001/ISO 45001 Certification Process Examples & Expectations at Each Stage– A 2-Part Case Study of PolyPeptide Group’s Journey

  • Morgan Heyman US Head of Environment, Health, Safety & Sustainability, PolyPeptide Group
  • Jordi Ramos Environmental Health & Safety Specialist, PolyPeptide Group

4:00 pm Chair’s Closing Remarks

4:30 pm Workshop A: Assessing Strategies for Efficient Risk Assessment & Risk Management Across Biopharma R&D & Manufacturing Sites

6:30 pm End of Day One